Abstracts tagged "race/ethnicity"

Abstract Number: 2688 • 2015 ACR/ARHP Annual Meeting
Socioeconomic Status, Ethnicity/Race, and Autoantibody Status in Rheumatoid Arthritis
Mercedes Quinones¹, Sharon Dowell¹, Gail S. Kerr², Christopher Swearingen³, Yusuf Yazici⁴, Luis Espinoza⁵, Ignacio Garcia-Valladares⁶, Edward L. Treadwell⁷, Theresa Lawrence Ford⁸, Yvonne Scherrer⁹, Angelia Mosley-WIlliams¹⁰, Rodolfo Perez Alamino¹¹, Akgun Ince¹², John Amatruda¹³ and Jorge Flautero Arcos¹⁴, ¹Howard University Hospital, Washington, DC, ²Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ³Pediatrics & Biostatistics, University of Arkansas, Little Rock, AR, ⁴Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁵Medicine-Section of Rheumatology, LSU Medical Center, New Orleans, LA, ⁶Immunology & Rheumatology, Hospital General de Occidente, Zapopan, Jalisco, Mexico, ⁷Dept Medicine Div of Rheum, E Carolina Univ Sch of Med, Greenville, NC, ⁸North Georgia Rheumatology Group, PC, Lawrenceville, GA, ⁹Center for Rheumatology & Immunology Arthritis, Fort Lauderdale, FL, ¹⁰John Dingell VAMC, Detroit, MI, ¹¹Rheumatology, Lousiana State University and LSU Medical Center, New Orleans, LA, ¹²Arthitis Consultants Inc, St. Louis University, St. Louis, MO, ¹³Rheumatology, Howard University, Washington, DC, ¹⁴Rheumatology, Howard University Hospital, Washington, DC
Background/Purpose: Ethnic disparities in outcomes of RA patients have been attributed to delayed presentation to specialty care and access to DMARDs, greater disease burden, and…
Abstract Number: 972 • 2014 ACR/ARHP Annual Meeting
Racial, Gender and Geographic Differences in Systemic Lupus Erythematous and Lupus Nephritis Mortality Rates in the Unites States, 1968-2010
Eric Y Yen¹, Magda Shaheen², Jennifer MP Woo³, Deborah K. McCurdy⁴ and Ram Raj Singh⁵, ¹Pediatrics/Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, ²Charles R. Drew University of Medicine and Science, Los Angeles, CA, ³UCLA Division of Pediatric Rheumatology, Los Angeles, CA, ⁴Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, ⁵Medicine, UCLA Division of Rheumatology, Los Angeles, CA
Title: Racial, Gender and Geographic Differences in Systemic Lupus Erythematous and Lupus Nephritis Mortality Rates in the Unites States, 1968-2010Background/Purpose: Many epidemiologic studies of systemic…
Abstract Number: 734 • 2014 ACR/ARHP Annual Meeting
Lower Socioeconomic Status, Male Gender and Diffuse Scleroderma Are Associated with Worse Survival in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort
Jessica K. Gordon¹, Wei Zhang², Lorinda Chung³, Yan Ma⁴, Virginia D. Steen⁵ and PHAROS Investigators, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Healthcare Research Institute, Hospital for Special Surgery, New York, NY, ³Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, ⁴Research - Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, ⁵Department of Rheumatology, Georgetown University Medical Center, Washington, DC
Background/Purpose Lower socioeconomic status (SES) and male gender have been associated with worse survival in idiopathic pulmonary arterial hypertension (PAH). Pulmonary Hypertension Assessment and Recognition…
Abstract Number: 2841 • 2014 ACR/ARHP Annual Meeting
Identifying Novel Lupus Severity Risk Variants through Identification of Alleles with High Ethnic Variability Worldwide
Belinda A. Waltman¹, Kimberly E. Taylor², Julio Molineros³, Sarah French⁴, Joanne Nitiham¹, Jennifer Kelly³, Adam Adler⁵, Judith A. James³, Swapan Nath⁶, Marta Alarcon-Riquelme^3,7 and Lindsey A. Criswell¹, ¹Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, ²Department of Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, ³Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁴School of Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, ⁵Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁶Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁷GENYO. Center for Genomics and Oncological Research, Granada, Spain
Background/Purpose: Substantial epidemiologic evidence demonstrates that SLE disproportionately affects minority patients in terms of incidence, prevalence, and disease severity. European ancestry has been associated with…
Abstract Number: 2051 • 2014 ACR/ARHP Annual Meeting
Modification of Effects of Household Income and Homeownership By Block Group Poverty on Health Outcomes in a Cohort of African Americans with Rheumatoid Arthritis
Rebecca J. Cleveland¹, Jennifer Smith², Antoine A. Baldassari¹, Beth L. Jonas³, Doyt L. Conn⁴, Larry W. Moreland⁵, S. Louis Bridges Jr.⁶ and Leigh F. Callahan⁷, ¹Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Heritage College of Medicine, Ohio University, Athens, OH, ³Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Rheumatology, Emory Univ School of Medicine, Atlanta, GA, ⁵University of Pittsburgh, Pittsburgh, PA, ⁶University of Alabama at Birmingham, Birmingham, AL, ⁷Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC
Background/Purpose We previously found that household income less than $30k/yr and not owning a home influenced rheumatoid arthritis (RA) disease severity measures. We sought to…
Abstract Number: 697 • 2012 ACR/ARHP Annual Meeting
Demographic, Clinical, Serologic and Socioeconomic Measures Each Predict Mortality in Scleroderma
Allan C. Gelber¹, Rebecca L. Manno², Adrianne Woods¹, Ami A. Shah³, Francesco Boin³, Laura K. Hummers³ and Fredrick M. Wigley³, ¹Medicine/ Rheumatology, Johns Hopkins University, Baltimore, MD, ²Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ³Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Multivariate Model 1 Adjusted RR 95%CI Multivariate Model 2 Adjusted RR 95%CI Male vs Female 1.4 1.1 – 1.9 Male vs Female 1,4…
Abstract Number: 382 • 2012 ACR/ARHP Annual Meeting
Does Biased Risk Perception Explain the Underuse of Disease Modifying Anti-Rheumatic Drugs?
Richard W. Martin¹, Andrew J. Head², James D. Birmingham³ and Aaron T. Eggebeen¹, ¹Medicine, Rheumatology, Michigan State University College of Human Medicine, Grand Rapids, MI, ²Medicine, Rheumatology, College of Human Medicine, Michigan State University, Grand Rapids, MI, ³Medicine & Pediatrics, Rheumatology, Michigan State University College of Human Medicine, Grand Rapids, MI
Background/Purpose: The prescription of a Disease Modifying Anti-rheumatic Drugs (DMARD) for patients with rheumatoid arthritis (RA) is considered a standard of effective care. However a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].